SOURCE: North American Partners in Anesthesia

North American Partners in Anesthesia

May 22, 2013 10:20 ET

North American Partners in Anesthesia Announces Expansion With Addition of New Jersey Anesthesia Group to Its Ranks

Addition of Prominent Anesthesia Practice Fuels Strategic Growth

MELVILLE, NY--(Marketwired - May 22, 2013) - North American Partners in Anesthesia (NAPA), the largest single specialty anesthesia and perioperative management company in the United States, today announced New Jersey Anesthesia Group (NJAG), located in Paterson, NJ, has joined NAPA. With the addition of NJAG, NAPA continues its expansion in the New Jersey anesthesia market. An additional 73 NJAG clinicians will join NAPA's operations.

"From our first interactions with NJAG leadership, it was clear that NAPA and NJAG shared a similar clinical philosophy and approach to delivering care," said Timothy J. Dowd, CEO and Managing Partner of North American Partners in Anesthesia. "As NAPA looks to strategically expand, we are seeking high quality practices with a strong leadership and focus, which is exactly what NJAG embodies. We look forward to providing our newest partner with the foundation to flourish and continue to advance our shared goal of providing quality anesthesia care."

New Jersey Anesthesia Group is a multifaceted anesthesia practice located in northern New Jersey. The group provides anesthesia services for St. Joseph's Regional Medical Center, St. Joseph's Wayne Hospital, Meadowlands Hospital Medical Center, and St. Michael's Medical Center. In addition, NJAG provides anesthesia services to more than 12 outpatient facilities in the region. Total Pain Care, a division of NJAG that delivers state-of-the-art pain management services in Passaic and Bergen counties, is also included in the transaction.

 "NJAG was attracted to NAPA because of its commitment to clinical excellence and leading infrastructure to support our facility clients in an evolving healthcare environment," said Stephen Winikoff, M.D., president of NJAG. "At our core is quality, and joining NAPA will enable us to continue to practice medicine with the same local focus on quality, while incorporating the business infrastructure NAPA offers. NAPA's wealth of knowledge, data and resources will provide our clinicians with the essential tools to continue to improve the quality of patient care we provide as well as enhance our residency program."

In April 2011, Moelis Capital Partners, the private equity business of Moelis & Company, led a recapitalization of NAPA's practice management company, NAPA Management Services Corporation (NMSC) providing the company with the ability to pursue growth opportunities and maintain its leadership position in the expanding anesthesia management market.

About North American Partners in Anesthesia

Founded in 1986, North American Partners in Anesthesia (NAPA) is the leading single specialty anesthesia management company in the United States. NAPA is comprised of the most respected clinical staff, providing thousands of patients with superior and attentive care. The company is known for partnering with hospitals and other health care facilities across the nation to provide anesthesia services and perioperative leadership that maximize operating room performance, enhance revenue, and demonstrate consistent patient and surgeon satisfaction ratings. For more information, please visit

About New Jersey Anesthesia Group

Founded in 1988, New Jersey Anesthesia Group has developed into the preeminent provider of anesthetic care and pain services in northern New Jersey. The dedicated physicians of NJAG span many subspecialties of anesthesiology including pediatrics, obstetrics, cardiac, neurosurgery and pain medicine. NJAG has one of the largest residency programs in the state of New Jersey and is an affiliate of Mount Sinai School of Medicine.


Moelis Capital Partners is a middle market private equity firm founded in 2007 in connection with the formation of Moelis & Company, a global investment bank. Moelis Capital Partners manages $800 million of committed private equity capital and specializes in traditional private equity investments in the middle market. For more information, please visit

Contact Information